Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             29 results found
no title author magazine year volume issue page(s) type
1 Abstracts 2010
50 9 p. 1058-1095
article
2 ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics Brundage, Richard C.
2010
50 9 p. 7S-8S
article
3 Antiviral Information Management System (AIMS): A Prototype for Operational Innovation in Drug Development Jadhav, Pravin R.
2010
50 9 p. 50S-55S
article
4 A Proof-of-Concept and Drug-Drug Interaction Study of Pamapimod, a Novel p38 MAP Kinase Inhibitor, With Methotrexate in Patients With Rheumatoid Arthritis Xiaoping Zhang,
2010
50 9 p. 1031-1038
article
5 Bridging Pharmacology and Pathophysiology via Systems Modeling D'Argenio, David Z.
2010
50 9 p. 56S-57S
article
6 Defining the Future of Pharmacometrics: The American Society of Pharmacometrics Pfister, Marc
2010
50 9 p. 158S-158S
article
7 Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers Bergman, Ebba
2010
50 9 p. 1039-1049
article
8 Effects of the Peroxisome Proliferator Activated Receptor-γ Coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser Polymorphisms on Rosiglitazone Response in Chinese Patients With Type 2 Diabetes Mellitus Zhang, Ke-Han
2010
50 9 p. 1022-1030
article
9 Evaluation and Recommendations on Adaptive Dose-Ranging Trials: Highlights From the PhRMA Adaptive Dose-Ranging Studies Working Group Pinheiro, José
2010
50 9 p. 47S-49S
article
10 Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis Doshi, Sameer
2010
50 9 p. 75S-90S
article
11 Fostering Culture and Optimizing Organizational Structure for Implementing Model-Based Drug Development Liping Zhang,
2010
50 9 p. 146S-150S
article
12 Interactive Visualization and Communication for Increased Impact of Pharmacometrics Krause, Andreas
2010
50 9 p. 140S-145S
article
13 Is There an Association Between 5-Azacitidine and Ototoxicity? Malik, Afshan
2010
50 9 p. 1056-1057
article
14 Lisdexamfetamine Dimesylate: Linear Dose-Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open-Label Single-Dose Pharmacokinetic Study in Healthy Adult Volunteers Ermer, James
2010
50 9 p. 1001-1010
article
15 Missing Data in Model-Based Pharmacometric Applications: Points to Consider Gastonguay, Marc R.
2010
50 9 p. 63S-74S
article
16 Model-Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development Wetherington, Jeffrey D.
2010
50 9 p. 31S-46S
article
17 Model-Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry Stone, Julie A.
2010
50 9 p. 20S-30S
article
18 Models for Event-Driven Data: Longitudinal Daily Adverse Event and Dropout Miller, Raymond
2010
50 9 p. 58S-62S
article
19 Pharmacometrics 2020 Gobburu, Jogarao V. S.
2010
50 9 p. 151S-157S
article
20 Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success Romero, Klaus
2010
50 9 p. 9S-19S
article
21 Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations Krzyzanski, Wojciech
2010
50 9 p. 101S-112S
article
22 Population Pharmacokinetic-Pharmacodynamic Modeling of Biological Agents: When Modeling Meets Reality Mould, Diane R.
2010
50 9 p. 91S-100S
article
23 Review: Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban Morell, Jason
2010
50 9 p. 986-1000
article
24 Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients Thyssen, An
2010
50 9 p. 1011-1021
article
25 Synergy Between Scientific Advancement and Technological Innovation, Illustrated by a Mechanism-Based Model Characterizing Sodium—Glucose Cotransporter-2 Inhibition Liping Zhang,
2010
50 9 p. 113S-120S
article
26 The Effect of Acid Reduction With a Proton Pump Inhibitor on the Pharmacokinetics of Lopinavir or Ritonavir in HIV-Infected Patients on Lopinavir/Ritonavir-Based Therapy Overton, Edgar T.
2010
50 9 p. 1050-1055
article
27 The Emerging Scientific Discipline of Pharmacometrics Pfister, Marc
2010
50 9 p. 6S-6S
article
28 The Need for Modeling and Simulation to Design Clinical Investigations in Children Jadhav, Pravin R.
2010
50 9 p. 121S-129S
article
29 Visualization Concepts to Enhance Quantitative Decision Making in Drug Development Dykstra, Kevin
2010
50 9 p. 130S-139S
article
                             29 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands